Mara S. Varvil

Mara S. Varvil

Auto-generated profile, based on publicly available information

Mara S. Varvil

Veterinary Clinical Sciences, College of Veterinary Medicine, College of Arts and Sciences, Washington State University, Pullman, WA, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2022 in Veterinary Clinical Pathology
Verified
Journal Article
Closed access
PDF file
MVMara S. Varvil
Mara S. Varvil
JMJoanne B. Messick
Joanne B. Messick
ASAndrea Pires dos Santos
Andrea Pires dos Santos

28 November 2023 in Journal of Veterinary Diagnostic Investigation
Verified
Journal Article
Closed access
MVMara S. Varvil
Mara S. Varvil
SCSamuel L. Clark
Samuel L. Clark
TBTaylor W. Bailey
Taylor W. Bailey
JRJosé A. Ramos-Vara
José A. Ramos-Vara
ASAndrea Pires dos Santos
Andrea Pires dos Santos
We assessed the effects of fixation time in formalin and inclusion of surrounding tissue on microRNA (miRNA) cycle quantification (Cq) values in formalin-fixed, paraffin-embedded (FFPE) urothelial carcinoma (UC) tissue ( n = 3), and the effect of conditions on miRNAs in urine from 1 healthy dog. MiRNAs were extracted using commercial kits and quantified using miRNA-specific fluorometry in normal bladder tissue scrolls, UC tissue cores, and bladder muscularis tissue cores from 4 FFPE bladder sections (3 UCs, 1 normal), plus 1 UC stored in formalin for 1, 8, 15, and 22 d before paraffin-embedding. Urine was collected from a healthy dog on 4 occasions; 1-mL aliquots were stored at 20, 4, −20, and −80°C for 4, 8, 24, and 48 h, and 1 and 2 wk. For both FFPE tissue and urine, we used reverse-transcription quantitative real-time PCR (RT-qPCR) to quantify miR-143, miR-152, miR-181a, miR-214, miR-1842, and RNU6B in each tissue or sample, using miR-39 as an exogenous control gene. The Cq values were compared with ANOVA and t-tests. The time of tissue-fixation in formalin did not alter miRNA Cq values; inclusion of the muscularis layer resulted in a statistically different miRNA Cq profile for miR-152, miR-181a, and RNU6B in bladder tissue. MiRNAs in acellular urine were stable for up to 2 wk regardless of the storage temperature. Our findings support using stored FFPE and urine samples for miRNA detection; we recommend measuring miRNA only in the tissue of interest in FFPE sections.

6 May 2019 in Veterinary Clinical Pathology
Verified
Journal Article
Closed access
PDF file
MVMara S. Varvil
Mara S. Varvil
GHGillian Haanen
Gillian Haanen
MSMario F. Sola
Mario F. Sola
TLTsang Lin
Tsang Lin
JKJanice E. Kritchevsky
Janice E. Kritchevsky
JCJohn A. Christian
John A. Christian

1 October 2024 in American Journal of Veterinary Research
Verified
Journal Article
Open access
PDF file
MVMara S. Varvil
Mara S. Varvil
ASAndrea Pires dos Santos
Andrea Pires dos Santos
Urothelial carcinoma (UC) is the most common urogenital cancer in dogs. With early diagnosis, the disease can be controlled, to reduce progression of disease, in most dogs with a good quality of life. MicroRNAs (miRNAs) have been identified as a potential diagnostic and prognostic tool due to their stability and presence in both bodily fluids and tissues. MiRNAs have been frequently researched in human medicine and human UC; however, few manuscripts regarding miRNAs in canine UC are available. A search was performed on both PubMed and Google Scholar evaluating original research manuscripts with experimentally validated results for the terms “canine” or “dog”; “urothelial carcinoma,” “bladder cancer,” “transitional cell carcinoma,” “TCC,” “MIBC,” “IMBUC,” or “BLCA”; and “miRNA” or “microRNA.” We identified 3 peer-reviewed manuscripts evaluating miRNA expression in canine UC and compared the reported miRNA expression studies to human UC to identify experimentally validated targets of the dysregulated miRNA. In this review, we highlight the similarities and differences between what is reported in canine UC and human UC and discuss the literature gaps that call for further evaluation.

1 December 2018 in Veterinary Clinical Pathology
Verified
Journal Article
Closed access
PDF file
MVMara S. Varvil
Mara S. Varvil
LCLorraine A. Corriveau
Lorraine A. Corriveau
CTCraig A. Thompson
Craig A. Thompson

11 October 2025 in Veterinary Clinical Pathology
Verified
Journal Article
Open access
HCHannah R. Cohen
Hannah R. Cohen
MWMatthew K. Wun
Matthew K. Wun
JHJillian Haines
Jillian Haines
SGSarah C. Guess
Sarah C. Guess
MVMara S. Varvil
Mara S. Varvil
KWK. Jane Wardrop
K. Jane Wardrop
A 3‐year‐old, intact female Havanese dog was presented for treatment of a relapse of suspected immune‐mediated anemia and thrombocytopenia. Over the course of treatment, the patient's anemia appeared to acutely transition from macrocytic and hypochromic to microcytic and hypochromic between days five and six of hospitalization. Assessment of red blood cell volume/hemoglobin content (RBC V/HC) cytograms produced on the ADVIA 2120i (Siemens Healthcare Diagnostics, Munich, Germany) revealed a new population of microcytic and hypochromic erythrocytes on day six of hospitalization. This finding prompted the consideration that the microcytic and hypochromic erythrocyte population was introduced to the patient via a packed red blood cell (pRBC) transfusion, which was confirmed after running a sample of pRBCs from the same donor through the ADVIA 2120i. Other causes of microcytosis, such as iron deficiency anemia, portosystemic shunt, and hyponatremia, were additionally investigated and considered less likely. The cause of the microcytosis in the donor was ultimately undetermined. To the authors' knowledge, this is the first case where inadvertent transfusion with microcytic pRBCs was discovered with the aid of RBC V/HC cytograms. This case highlights the importance of considering pRBCs as a source of changes in erythrocyte indices as well as the utility of RBC V/HC cytograms in patients with multiple populations of erythrocytes, such as those receiving transfusions. Additionally, this case prompts reconsideration of the need for standardization of guidelines for blood donation frequency and monitoring of iron status in frequent blood donors.